Clinigen Group PLC
LSE:CLIN

Watchlist Manager
Clinigen Group PLC Logo
Clinigen Group PLC
LSE:CLIN
Watchlist
Price: 925 GBX
Market Cap: 1.2B GBX

Wall Street
Price Targets

CLIN Price Targets Summary
Clinigen Group PLC

There are no price targets for CLIN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Clinigen Group PLC Competitors:
Price Targets
688222
HitGen Inc
18% Upside
LAB
Standard BioTools Inc
24% Upside
PPGN
PolyPeptide Group AG
36% Upside
CSBR
Champions Oncology Inc
84% Upside
ERF
Eurofins Scientific SE
0% Upside
SYNGENE
Syngene International Ltd
11% Upside
CTKB
Cytek Biosciences Inc
19% Upside

Revenue
Forecast

Revenue Estimate
Clinigen Group PLC

For the last 8 years the compound annual growth rate for Clinigen Group PLC's revenue is 20%. The projected CAGR for the next 6 years is -13%.

20%
Past Growth
-13%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Clinigen Group PLC

Operating Income forecast
is not available for
Clinigen Group PLC

Net Income
Forecast

Net Income Estimate
Clinigen Group PLC

Net Income forecast
is not available for
Clinigen Group PLC
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLIN's stock price target?
Not Available

CLIN doesn't have any price targets made by Wall Street professionals.

What is Clinigen Group PLC's Revenue forecast?
Projected CAGR
-13%

For the last 8 years the compound annual growth rate for Clinigen Group PLC's revenue is 20%. The projected CAGR for the next 6 years is -13%.

Back to Top